Author: Fortrea Holdings Inc

Posted Date:

April 7, 2026

Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials

Fortrea Holdings Inc

April 7, 2026
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fortrea Holdings Inc

March 10, 2026
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services

Fortrea Holdings Inc

February 17, 2026
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

Fortrea Holdings Inc

January 29, 2026